Petar Bibulić

Title: Petar Bibulić: Innovator in Pharmaceutical Chemistry

Introduction

Petar Bibulić is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of various compounds. With a total of 2 patents, his work is recognized for its innovative approach to drug formulation.

Latest Patents

Bibulić's latest patents include the development of novel solid-state forms of Aprocitentan, which encompasses Aprocitentan salts and co-crystals. This patent details processes for the preparation of these forms and their pharmaceutical compositions. Another significant patent focuses on solid-state forms of Encequidar, previously referred to as HM-30181A, including its mesylate salt and co-crystals. This work also outlines the processes for preparation and the pharmaceutical compositions that incorporate these forms.

Career Highlights

Petar Bibulić is currently associated with Assia Chemical Industries Ltd., where he applies his expertise in pharmaceutical development. His innovative work has contributed to advancements in drug formulation, enhancing the efficacy and stability of pharmaceutical products.

Collaborations

Throughout his career, Bibulić has collaborated with talented professionals, including Dijana Škalec Šamec and Marina Marinković. These collaborations have fostered a creative environment that promotes innovation in pharmaceutical research.

Conclusion

Petar Bibulić stands out as a significant figure in the field of pharmaceutical chemistry, with his innovative patents paving the way for advancements in drug formulation. His contributions continue to impact the industry positively.